Men
Tackling the issues men need to focus on to live their best life
-
Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence
Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.
-
Clinical trials matter, just ask Randy
When Randy was diagnosed with small cell lung cancer, he thought it was time to get his affairs in order. But a phase I clinical trial at Providence Cancer Institute gave him more time and hope.
-
A comprehensive guide to men’s health
From cancer screenings to testosterone, explore this expert-backed guide from Providence covering key health topics every man should know.
- GET THE APP ›
-
Healthier births start here: Join Providence Everett CenteringPregnancy
Discover the benefits of CenteringPregnancy at Providence Swedish Everett. Learn how this unique prenatal care model offers midwifery support in a group setting.
-
From life-saving surgery to back on the slopes: A photographer’s story
Gary tells his story about the difficult journey back to the slopes of Mt. Hood after receiving life-saving surgery for pancreatic cancer.
-
Signs Your Partner's New Year's Promises Are Just Empty Words
Discover the signs of healthy & toxic relationships and get help towards a better future with support from Providence's Intervention Center for Assault and Abuse (PICAA).
-
Providence Everett Honored for Excellence in Maternity Care
U.S. News & World Report named Providence Regional Medical Center Everett (PRMCE) a 2025 High Performing Hospital for Maternity Care.
-
A year to remember: Advancements, recognition and transitions
Catch the 2024 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.
-
CAR T cell-therapy, hope and healing: Dean’s story
Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.
- FIND A CLINIC ›
-
Providence Swedish North offers free STOP THE BLEED® training
Providence Swedish North is offering free STOP THE BLEED® training at Providence Regional Medical Center Everett.
-
Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
-
New studies test immunotherapy to boost breast cancer treatment and prevent return
Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.
-
Attend a free virtual symposium on melanoma, Oct. 25
Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.
-
Understanding seasonal affective disorder (SAD)
Don’t get SAD. An expert at Providence answers common questions to help you understand seasonal affective disorder.
-
Prostate cancer study includes a tumor test to personalize treatment
A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.
-
Providence Swedish earns national recognitions from American Heart Association
The awards highlight Providence Swedish's consistency in following the American Heart Association's guidelines for care, treatment and improved outcomes in stroke and diabetes.
-
Cancer survivor speaks with doctor he credits for saving his life
Cancer survivor Mark Williams chats with Dr. Brendan Curti about
-
2024 Hood to Coast Relay: Providence team captains tell us why they run
What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.
-
Providence Community Cancer Screening Event
Providence Community Cancer Screening Event
-
Targeting cancer cells: Two studies take different approaches
A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec
-
Loading More...